Avanir proposes follow on

Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) said late Tuesday it is planning a follow-on underwritten by Jefferies; Canaccord; Wedbush; Summer Street Research Partners; and Merriman. Further details were not disclosed. Trout Capital is advising Avanir. ...